Patents by Inventor Lisa Kay Lupton

Lisa Kay Lupton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bulk polyethylene glycol compositions
    Patent number: 11793876
    Abstract: The present invention relates to bulk dry compositions comprising polyethylene glycol and an additive, such as a flavoring agent and/or sweetener, wherein the additive remains at a consistent concentration throughout the bulk composition. The invention also relates to processes for preparing the bulk dry compositions comprising polyethylene glycol.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: October 24, 2023
    Assignee: L. PERRIGO COMPANY
    Inventors: Lisa Kay Lupton, Kiran Kumar Muppireddy, Inderdeep Bhatia, Carlos O. Paz, Bruce D. Johnson
  • Dextromethorphan extended release pharmaceutical composition
    Patent number: 11701350
    Abstract: The invention is directed to pharmaceutical compositions comprising dextromethorphan and methods of use thereof. Formulations of the present invention include dextromethorphan or a pharmaceutically acceptable salt thereof in a sustained release formulation comprising a controlled release agent. Formulations of the present invention include a core tablet, optionally an active coating and, optionally a film coating. The pharmaceutical compositions may be used as an antitussive, and the invention further relates to the treatment of cough in a patient in need thereof.
    Type: Grant
    Filed: July 22, 2020
    Date of Patent: July 18, 2023
    Assignee: L. PERRIGO COMPANY
    Inventors: Kiran Kumar Muppireddy, Inderdeep Singh Bhatia, Eric Cristopher Pattok, Carlos O. Paz, Bruce Duane Johnson, Lisa Kay Lupton
  • BULK POLYETHYLENE GLYCOL COMPOSITIONS
    Publication number: 20210113698
    Abstract: The present invention relates to bulk dry compositions comprising polyethylene glycol and an additive, such as a flavoring agent and/or sweetener, wherein the additive remains at a consistent concentration throughout the bulk composition. The invention also relates to processes for preparing the bulk dry compositions comprising polyethylene glycol.
    Type: Application
    Filed: October 16, 2020
    Publication date: April 22, 2021
    Inventors: Lisa Kay Lupton, Kiran Kumar Muppireddy, Inderdeep Bhatia, Carlos O. Paz, Bruce D. Johnson
  • DEXTROMETHORPHAN EXTENDED RELEASE PHARMACEUTICAL COMPOSITION
    Publication number: 20210023073
    Abstract: The invention is directed to pharmaceutical compositions comprising dextromethorphan and methods of use thereof. Formulations of the present invention include dextromethorphan or a pharmaceutically acceptable salt thereof in a sustained release formulation comprising a controlled release agent. Formulations of the present invention include a core tablet, optionally an active coating and, optionally a film coating. The pharmaceutical compositions may be used as an antitussive, and the invention further relates to the treatment of cough in a patient in need thereof.
    Type: Application
    Filed: July 22, 2020
    Publication date: January 28, 2021
    Inventors: Kiran Kumar Muppireddy, Inderdeep Singh Bhatia, Eric Cristopher Pattok, Carlos O. Paz, Bruce Duane Johnson, Lisa Kay Lupton